(NASDAQ: SLGL) Sol Gel Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.9%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.82%.
Sol Gel Technologies's earnings in 2026 is -$1,046,000.On average, 6 Wall Street analysts forecast SLGL's earnings for 2026 to be -$28,425,511, with the lowest SLGL earnings forecast at -$41,743,054, and the highest SLGL earnings forecast at -$16,990,581. On average, 5 Wall Street analysts forecast SLGL's earnings for 2027 to be -$30,687,326, with the lowest SLGL earnings forecast at -$53,852,704, and the highest SLGL earnings forecast at -$16,990,581.
In 2028, SLGL is forecast to generate -$7,168,897 in earnings, with the lowest earnings forecast at -$11,212,639 and the highest earnings forecast at -$2,745,952.